AI Article Synopsis
- The French National Cancer Institute updated guidelines for ductal carcinoma in situ (DCIS) due to concerns about overdiagnosis and overtreatment since the last guidelines in 2009.
- The update involved a thorough review of current literature and input from a multidisciplinary group of experts, ensuring that recommendations are evidence-based and reflect expert consensus.
- The new guidelines specifically address MRI and vacuum-assisted breast biopsy indications, as well as management strategies for low-grade DCIS.
Article Abstract
Objective: Since the last guidelines published by the French National Cancer Institute (INCa) and the learning society "Société française de sénologie et de pathologie mammaire (SFSPM)" in 2009 about diagnosis and management of ductal carcinoma in situ, new data raised issues about overdiagnosis and its consequences, overtreatment. Therefore, an update was necessary, to provide healthcare professionals up-to-date guidelines and study therapeutic desescalation in particular.
Methods: The clinical practice guidelines development process is based on systematic literature review and critical appraisal by a multidisciplinary experts workgroup. The recommendations are thus based on the best available evidence and experts agreement. Prior to publication, the guidelines are also reviewed by more than 100 independent practitioners in cancer care delivery.
Results: This article presents French guidelines about MRI and vacuum assisted breast biopsy indications for DCIS diagnosis and the management of low-grade DCIS.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.annpat.2016.03.012 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!